We are live on ! Find out more
SLXNW

Silexion Therapeutics Warrant
SLXNW

31 hedge funds and large institutions have $106K invested in Silexion Therapeutics Warrant in 2024 Q3 according to their latest regulatory filings, with 31 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
31
Holders Change
+31
Holders Change %
–
% of All Funds
0.44%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
31
Increased
–
Reduced
–
Closed
–
Calls
$8K
Puts
–
Net Calls
+$8K
Net Calls Change
+$8K

Top Buyers

Rank Fund Capital Flow
1
PAMP
Polar Asset Management Partners
Ontario, Canada
+$43K
2
LA
Linden Advisors
New York
+$19.5K
3
AC
Aristeia Capital
Connecticut
+$14K
4
HP
Hartree Partners
New York
+$10.9K
5
SBLIC
Security Benefit Life Insurance Company
Kansas
+$8.69K

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
PAMP
1
Polar Asset Management Partners
Ontario, Canada
$23.6K +$43K +743,475 New
LA
2
Linden Advisors
New York
$17.1K +$19.5K +337,500 New
AC
3
Aristeia Capital
Connecticut
$12.3K +$14K +242,174 New
HP
4
Hartree Partners
New York
$5.63K +$10.9K +187,500 New
PC
5
Periscope Capital
Ontario, Canada
$5.3K +$6.05K +104,543 New
SBLIC
6
Security Benefit Life Insurance Company
Kansas
$4.72K +$8.69K +150,000 New
CS
7
Clear Street
New York
$4.34K +$7.93K +137,037 New
YCM
8
Yakira Capital Management
Connecticut
$3.81K +$4.34K +75,000 New
HCM
9
Highbridge Capital Management
New York
$3.5K – – –
PMAM
10
Picton Mahoney Asset Management
Ontario, Canada
$3K +$3.31K +57,175 New
KC
11
Kepos Capital
New York
$3K +$5.79K +100,000 New
Goldman Sachs
12
Goldman Sachs
New York
$2.94K +$5.4K +93,287 New
Jane Street
13
Jane Street
New York
$2.4K +$4.38K +75,721 New
CCM
14
Context Capital Management
California
$1.97K +$3.6K +62,238 New
TCM
15
Tenor Capital Management
New York
$1.58K +$2.9K +50,000 New
GCIA
16
Gabelli & Co Investment Advisers
New York
$1.21K +$2.21K +38,150 New
Susquehanna International Group
17
Susquehanna International Group
Pennsylvania
$1.1K +$2K +34,577 New
MTCM
18
Mint Tower Capital Management
Netherlands
$1K +$1.45K +25,000 New
Neuberger Berman Group
19
Neuberger Berman Group
New York
$1K +$1.83K +31,552 New
DCM
20
Dupont Capital Management
Delaware
$975 +$1.88K +32,500 New
GF
21
Gabelli Funds
New York
$967 +$1.77K +30,496 New
Walleye Capital
22
Walleye Capital
New York
$666 +$1.22K +21,000 New
SCM
23
Saba Capital Management
New York
$606 +$691 +11,937 New
Citadel Advisors
24
Citadel Advisors
Florida
$583 +$1.07K +18,405 New
Stifel Financial
25
Stifel Financial
Missouri
$504 +$926 +16,000 New
1
2

SLXNW Hedge Fund Activity: Q3 2024 in Review

31 of the 6,967 institutional investors tracked by Wall St. Rank reported a position in Silexion Therapeutics Warrant (SLXNW) for Q3 2024, worth a combined $106K.

Buyers outnumbered sellers: 31 funds opened new SLXNW positions and 0 closed out — a net gain of 31 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Polar Asset Management Partners, opening a new position worth an estimated $43K.

  • 31 institutional investors held Silexion Therapeutics Warrant (SLXNW) as of Q3 2024, up from 0 in Q2 2024.
  • Funds reported $106K of Silexion Therapeutics Warrant stock for Q3 2024.
  • 31 funds opened new Silexion Therapeutics Warrant positions in Q3 2024 and 0 closed out, a net change of +31 holders.
  • The largest Silexion Therapeutics Warrant buyer in Q3 2024 was Polar Asset Management Partners, an estimated $43K added.

Based on aggregated 13F filings for Q3 2024.